Warburg Pincus explores sale options for Modernizing Medicine - Reuters

Published 01/08/2025, 01:23 PM
© Reuters.

Investing.com -- Private equity firm Warburg Pincus is reportedly considering various options for Modernizing Medicine (ModMed), including a potential sale. The medical software provider could be valued at more than $5 billion, accounting for debt, according to Reuters insiders familiar with the situation.

ModMed, located in Boca Raton, Florida, is said to be working with a financial adviser to seek interest from possible buyers in the coming weeks. The pool of potential buyers includes other private equity firms.

Those familiar with the matter have indicated that these discussions are still in their early stages. They stressed that a deal is not guaranteed, and Warburg Pincus may decide to maintain its ownership of the company. ModMed also has the option to explore other alternatives, such as selling a stake in the company.

Warburg Pincus first invested in ModMed in 2017. The firm previously considered options for the company in 2022, but those discussions did not result in any action.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.